Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
Company Details
Ambys Medicines Questions
Ambys Medicines's helpline number is (650) 481-7660
Ambys Medicines's website is ambys.com
Ambys Medicines's LinkedIn profile is https://www.linkedin.com/company/ambys-medicines
Ambys Medicines has
14 employees.
View email and phone details for 14
employees at Ambys Medicines.
Ambys Medicines's industry is
Biotechnology Research
Ambys Medicines's top competitors are
Sangamo Therapeutics, Inc.,
Maze Therapeutics,
Revolution Medicines,
Septerna,
Metagenomi,
Tessera Therapeutics,
Arsenal Biosciences, Inc.,
Genedit,
Alumis,
Belharra Therapeutics.
Ambys Medicines's support email address is info@ambys.com
Ambys Medicines's categories are Biotechnology Research
Ambys Medicines's founding year is 2018
